Aterian Q3 Results: Outlook Remains Gloomy
Although Q3 2021 results came in above consensus on revenues and operating profit, we believe the overall picture on Aterian has not changed...
210 Views
Aterian: Killing Me Softly
ATER has renegotiated its financial debt and is being squeezed by its lender. In the short term, Aterian will suffer a massive capital dilution...
203 Views
Our Investment Thesis On Aterian Does Not Hold Anymore
ATER is set to fail to grow organically double-digit. We think they will be unable to move to double-digit EBITDA and command 50% FCFF...
229 Views
Aterian Update After Q1 2021: Valuation Looks Compelling After A Huge Sell-Off
Accretive M&A deals are difficult to achieve after price corrections. Aterian is inexpensive compared to its private market peer but...
223 Views